Skip to main content
Biocartis Group NV logo

Biocartis Group NV — Investor Relations & Filings

Ticker · BCART ISIN · BE0974281132 LEI · 549300J4HOJL5KG8HY54 BR Manufacturing
Open in API
Filings indexed 636 across all filing types
Latest filing 2023-09-26 Earnings Release
Country BE Belgium
Listing BR BCART

About Biocartis Group NV

https://www.biocartis.com/en

Biocartis Group NV is a molecular diagnostics company that develops and commercializes its proprietary Idylla™ platform. This fully automated, sample-to-result system is designed to provide fast, easy, and actionable molecular diagnostic results, making advanced testing accessible to laboratories of any size. The company's primary focus is in the field of oncology, offering a menu of tests that support the diagnosis and treatment of various cancers, including lung, colorectal, melanoma, and breast cancer. Biocartis aims to enable personalized medicine for patients by providing universal access to molecular testing. The company also collaborates with pharmaceutical partners in the development of companion diagnostics.

Recent filings

Filing Released Lang Actions
20230926 PR H1 2023 Results_ENG.pdf
Earnings Release Classification · 100% confidence The document explicitly states it announces 'H1 2023 Results' and that the results are 'prepared in accordance with IAS 34 \'Interim Financial Reporting\' as adopted by the European Union'. IAS 34 governs Interim Financial Reporting, which corresponds to the Interim / Quarterly Report category (IR). Although it also discusses a major recapitalization and reorganization, the primary financial reporting context is for the first half (H1) of the year, making 'IR' the most accurate classification for the financial content presented. The document is comprehensive, containing detailed financial tables and management commentary, distinguishing it from a mere Earnings Release (ER) or Report Publication Announcement (RPA). H1 2023
2023-09-26 English
20230926 PR H1 2023 Results_NL.pdf
Earnings Release Classification · 100% confidence The document is titled 'PERSBERICHT' (Press Release) and explicitly announces the 'RESULTATEN H1 2023' (H1 2023 Results). It provides key financial highlights (revenue growth, EBITDA, gross margin) and operational updates for the first half of the year. The text also mentions that the full consolidated financial statements are available in the 'halfjaarverslag 2023' (half-year report 2023) which is available via a link. Since this document is the announcement summarizing the results and referring to the comprehensive report elsewhere, it fits the definition of an Earnings Release (ER) or, given the comprehensive nature of the financial summary, potentially an Interim/Quarterly Report (IR). However, the structure strongly suggests an initial announcement of results, often accompanied by a call, which aligns best with an Earnings Release (ER). Furthermore, the document explicitly states it is prepared in accordance with IAS 34 'Interim financial reporting', which points towards an Interim/Quarterly Report (IR). Since it contains detailed financial tables and management commentary on the period, IR is a stronger fit than the brief ER, even though it is presented as a press release announcing the results. The document covers the first half (H1), making it a comprehensive interim report. H1 2023
2023-09-26 Dutch
20230718_cfo_announcement_eng.pdf
Board/Management Information Classification · 100% confidence The document is explicitly labeled as a "PRESS RELEASE INSIDE INFORMATION/ REGULATED INFORMATION" and announces the appointment of a new Chief Financial Officer (CFO) and Head of Service Delivery, George Cardoza. This type of announcement, detailing changes in senior management, directly corresponds to the definition of Board/Management Information (MANG). It is not a full annual report (10-K), an earnings release (ER) focusing on financial figures, or a transcript (CT).
2023-07-18 English
20230718_cfo_announcement_nl.pdf
Board/Management Information Classification · 100% confidence The document is a press release dated July 18, 2023, announcing the appointment of George Cardoza as the new Chief Financial Officer (CFO) and Head of Service Delivery for Biocartis Group NV. This type of announcement, detailing changes in senior management personnel, directly corresponds to the definition of 'Board/Management Information'. The document is not a full financial report (10-K or IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI). Therefore, the appropriate classification is MANG.
2023-07-18 Dutch
pr_outstanding_shares_june2023_eng.pdf
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Disclosure of Outstanding Voting Securities' and announces changes to the total outstanding share capital and voting rights following the conversion of convertible bonds during June 2023. It explicitly references compliance with the Belgian Act on the disclosure of major shareholdings and states that the Company will issue a press release at the end of each month with an update on further conversions and outstanding voting securities. This type of announcement, detailing changes in the number of shares and voting rights, directly relates to the structure of the company's equity and major shareholdings. While it is a regulatory disclosure, it is not a standard SEC form (like 10-K or DEF 14A). It specifically details changes in the total number of shares outstanding, which aligns closely with the concept of 'Share Issue/Capital Change' (SHA) or a notification related to major shareholdings. Given the context of disclosing the total number of voting rights and shares after conversions, and the mention of the Belgian Act on major shareholdings, the most fitting category is Major Shareholding Notification (MRQ), as these disclosures often accompany or trigger such notifications, or Share Issue/Capital Change (SHA). Since the core content is the calculation of total voting rights and potential shares issuable, SHA is a strong fit, but the context is explicitly about disclosure requirements related to voting rights thresholds (3%, 5%, 10%). However, the document is a direct announcement of the resulting share count, not a notification *from* a major shareholder crossing a threshold. It is a corporate action update affecting the total share base. Comparing SHA (Share Issue/Capital Change) and MRQ (Major Shareholding Notification), this document is a corporate disclosure about the *total* capital structure change, making SHA more appropriate than MRQ (which usually reports an individual entity crossing a threshold). Alternatively, since it is a specific regulatory disclosure not covered by other specific codes, it could fall under RNS. Given the specific nature of updating the total share count and voting rights, SHA is the best fit among the specific options.
2023-06-30 English
pr_outstanding_shares_june2023_nl_1.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "PERSBERICHT GEREGLEMENTEERDE INFORMATIE" (Regulated Information Press Release) and is dated June 30, 2023. The core content is the "Openbaarmaking van uitstaande stemrechtverlenende effecten" (Disclosure of outstanding voting securities). It details the conversion of convertible bonds into new shares and provides an updated summary of the total outstanding capital, voting rights, and potential future share issuances under various plans and loan agreements. This type of mandatory disclosure regarding changes in share capital structure and voting rights, issued via a press release, strongly aligns with regulatory reporting requirements concerning share ownership thresholds and capital structure updates. While it touches upon capital structure (CAP) and major shareholdings (MRQ), the primary function here is the mandatory public disclosure of the current voting rights structure following a corporate action (bond conversion). In the context of the provided definitions, this is a specific regulatory announcement. Since it is a formal disclosure of voting rights and capital structure changes, it fits best under the general category of regulatory filings or specific announcements related to share capital/voting rights. Given the focus on the total number of voting rights and the legal basis cited (Belgian Law regarding disclosure of significant shareholdings), it is a mandatory regulatory disclosure. It is not a full Annual Report (10-K), an Earnings Release (ER), or a simple Dividend Notice (DIV). It is a specific regulatory update. The closest fit among the specific codes related to capital/shareholder structure is either 'SHA' (Share Issue/Capital Change) or 'MRQ' (Major Shareholding Notification), but since it is a formal, mandatory disclosure of the total voting rights structure following a capital event, and it is presented as a press release, it functions as a general regulatory announcement. However, the content is highly specific to the total number of voting rights and potential shares, which is often reported under major shareholding rules or capital changes. Since the document explicitly details the calculation of total outstanding voting rights after a conversion, it is a direct update to the capital structure. I will classify this as a Capital/Financing Update (CAP) because the primary event discussed is the conversion of debt into equity, fundamentally changing the capital structure, or potentially SHA. Given the context of mandatory disclosure of voting rights following a capital change, SHA (Share Issue/Capital Change) is a strong candidate, but CAP covers financing activities leading to capital structure changes. Since the document is a formal press release announcing the resulting capital structure, and not just a general regulatory filing, I will lean towards the most specific category related to the change described: Share Issue/Capital Change (SHA). If SHA is too narrow, the general regulatory announcement (RNS) would apply, but SHA seems more precise for a conversion event. Revisiting the definitions: CAP is for fundraising/financing activities. SHA is for new share issues/capital changes. This document reports the *result* of a financing activity (bond conversion) leading to a share issue. SHA seems the most appropriate fit for reporting the resulting change in the number of shares/voting rights.
2023-06-30 Dutch

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.